Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Key neuropathological changes associated with late-onset dementia are not fully understood. Population-based longitudinal studies offer an opportunity to step back and examine which pathological indices best link to clinical state. CC75C is a longitudinal study of the population aged 75 and over at baseline in Cambridge, UK. We report on the first 213 participants coming to autopsy with sufficient information for an end of life dementia diagnosis. Clinical diagnosis was ascertained by examining retrospective informant interviews, survey responses, and death certificates according to DSM-IV criteria. The neuropathological protocol was based on the Consortium to Establish a Registry of Alzheimer's Disease (CERAD). Clinical dementia was present in 113 participants (53%): 67% with Alzheimer's disease, 4% vascular dementia, 22% mixed dementia, and 1% dementia with Lewy bodies. As Alzheimer-type pathology was common, the mutually blinded clinical and neuropathological diagnoses were not strongly related. Multivariable analysis identified associations between dementia during life and entorhinal cortex neuritic plaques, hippocampal diffuse plaques, neocortical neurofibrillary tangles, white matter pallor, Lewy bodies, and hippocampal atrophy. These results were consistent in those with clinical Alzheimer's disease. Vascular pathologies, especially microinfarcts, were more common in those with clinical diagnoses including vascular dementia. Alzheimer-type and cerebrovascular pathology are both common in the very old. A greater burden of these pathologies, Lewy bodies, and hippocampal atrophy, are associated with a higher risk of, but do not define, clinical dementia in old age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both lead to cognitive decline and dementia”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [5]
In the citing paper
“AD has generally been attributed to be the neuropathological cause in between 65% and 75% of dementia cases (42, 43).”
From Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 (2012) · cites this paper as [43]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 4×
“Subsequently participants whose MMSE scores suggested normal to high cognitive function were also recruited to the brain donation programme to ensure the sample included the full population spectrum.”
InfluentialMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“The “oldest-old” are the fastest-growing population group in developed countries and also have the greatest incidence of dementia [1].”
Self-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357 · cited 1×
“Ratings for tau reactive plaques and tangles were estimated according to Braak Staging [21] and ratings for diffuse amyloid-β-reactive plaques were estimated according to the age dependent CERAD protocol [20] for all areas.”
Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090 · cited 5×
“Besides the in-depth CAMDEX assessments made on many donors, retrospective interviews were sought with relatives after a donor’s death to obtain further information on the period between the participant’s last interview and death.”
MethodInfluentialSelf-citationMixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · cited 2×
“Furthermore, few of these studies have been able to compare neuropathology across clinically diagnosed dementia sub-types [4,7,9].”
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Self-citationCerebral White Matter Lesions and the Risk of Dementia
Prins, N. D., van Dijk, E. J., den Heijer, T., Vermeer, S. E., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.10.1531 · Cited by 488 · cited 1×
“White matter lesions have been reported in relation to dementia previously [9,27] and cognitive decline [28].”
Cited by
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544
Self-citationNelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz099 · Cited by 1,547
Self-citationBeach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b211b · Cited by 1,103
“There are many alternate causes of dementia in the elderly, and AD has generally been attributed to be the neuropathologic cause in 65% to 75% of dementia cases (42, 43).”
BackgroundWebster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755
“…et al., 2002; Guillozet et al., 2003; Bennett et al., 2004; Kraybill et al., 2005; Holtzer et al., 2006; Markesbery et al., 2006; Koepsell et al., 2008; Whitwell et al., 2008; Beach et al., 2009; Brayne et al., 2009; Giannakopoulos et al., 2009; Sabbagh et al., 2010; Robinson et al., 2011).”
BackgroundImpact of multiple pathologies on the threshold for clinically overt dementia
Kapasi, A., DeCarli, C., & Schneider, J. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1717-7 · Cited by 739
“Indeed, microinfarcts are also highly prevalent in persons with probable AD, vascular dementia, and mixed dementia [19, 43, 130].”
BackgroundThe overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
Castellani, R. J., Rolston, R. K., & Smith, M. A. (2010) · Disease-a-Month · doi:10.1016/j.disamonth.2010.06.001 · Cited by 519
Person-specific contribution of neuropathologies to cognitive loss in old age
Boyle, P. A., Yu, L., Wilson, R. S., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2018) · Annals of Neurology · doi:10.1002/ana.25123 · Cited by 508
“Although it is increasingly recognized that the brains of older persons frequently exhibit mixed neuropathology and that mixed neuropathology is the most common cause of dementia, prior studies have not examined patterns of comorbidity considering all 9 of the neuropathologies studied here.(1,2,4,12,13) Taking all of…”
BackgroundCerebral microinfarcts: the invisible lesions
Smith, E. E., Schneider, J. A., Wardlaw, J. M., & Greenberg, S. M. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70307-6 · Cited by 456
Microinfarct Pathology, Dementia, and Cognitive Systems
Arvanitakis, Z., Leurgans, S. E., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2011) · Stroke · doi:10.1161/strokeaha.110.595082 · Cited by 404
Education, the brain and dementia: neuroprotection or compensation?
Brayne, C., Ince, P. G., Keage, H. A. D., McKeith, I. G., Matthews, F. E., Polvikoski, T., & Sulkava, R. (2010) · Brain · doi:10.1093/brain/awq185 · Cited by 392
“In MRC CFAS (Savva et al., 2009) and CC75C (Brayne et al., 2009), classification was based on all information available for each participant including any interview during the last years of life, a retrospective informant interview after death and the death certificate.”
Self-citationAntioxidant Therapies for Alzheimer's Disease
Feng, Y., & Wang, X. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/472932 · Cited by 379
“been reported that 76% of brains of cognitively intact elderly patients were interpreted as AD brains [20].”
BackgroundPrevalence of mixed pathologies in the aging brain
Rahimi, J., & Kovacs, G. G. (2014) · Alzheimer's Research & Therapy · doi:10.1186/s13195-014-0082-1 · Cited by 364
Pathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353
Skrobot, O. A., Attems, J., Esiri, M., Hortobágyi, T., Ironside, J. W., Kalaria, R. N., King, A., Lammie, G. A., Mann, D., Neal, J., et al. (2016) · Brain · doi:10.1093/brain/aww214 · Cited by 320
“However, the findings are of potential interest and are in keeping with other neuropathological data suggesting that vascular disease plays an increasingly important role in the development of dementia in the very old (Brayne et al., 2009).”
ResultAttributable risk of Alzheimer's dementia attributed to age-related neuropathologies
Boyle, P. A., Yu, L., Leurgans, S. E., Wilson, R. S., Brookmeyer, R., Schneider, J. A., & Bennett, D. A. (2019) · Annals of Neurology · doi:10.1002/ana.25380 · Cited by 318
Prevalence of dementia disorders in the oldest-old: an autopsy study
Jellinger, K. A., & Attems, J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0654-5 · Cited by 276
Stroke, Vascular Dementia, and Alzheimer’s Disease: Molecular Links
Vijayan, M., & Reddy, P. H. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160527 · Cited by 261
Cerebral Microinfarcts: A Systematic Review of Neuropathological Studies
Brundel, M., de Bresser, J., van Dillen, J. J., Kappelle, L. J., & Biessels, G. J. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.200 · Cited by 258
Kalaria, R. N. (2012) · Stroke · doi:10.1161/strokeaha.112.655803 · Cited by 227
To what degree is late life cognitive decline driven by age-related neuropathologies?
Boyle, P. A., Wang, T., Yu, L., Wilson, R. S., Dawe, R., Arfanakis, K., Schneider, J. A., & Bennett, D. A. (2021) · Brain · doi:10.1093/brain/awab092 · Cited by 219
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts
Arvanitakis, Z., Capuano, A. W., Leurgans, S. E., Buchman, A. S., Bennett, D. A., & Schneider, J. A. (2017) · Brain Pathology · doi:10.1111/bpa.12365 · Cited by 194
Chertkow, H., Feldman, H. H., Jacova, C., & Massoud, F. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt198 · Cited by 194
Understanding the Amyloid Hypothesis in Alzheimer’s Disease
Paroni, G., Bisceglia, P., & Seripa, D. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180802 · Cited by 187
Chornenkyy, Y., Wang, W., Wei, A., & Nelson, P. T. (2019) · Brain Pathology · doi:10.1111/bpa.12655 · Cited by 184
Cognitive Deficits and Delayed Neuronal Loss in a Mouse Model of Multiple Microinfarcts
Wang, M., Iliff, J. J., Liao, Y., Chen, M. J., Shinseki, M. S., Venkataraman, A., Cheung, J., Wang, W., & Nedergaard, M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-12.2012 · Cited by 182
Concomitant vascular and neurodegenerative pathologies double the risk of dementia
Azarpazhooh, M. R., Avan, A., Cipriano, L. E., Munoz, D. G., Sposato, L. A., & Hachinski, V. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.07.755 · Cited by 175
“Almost all included studies were to some extent biased with their inclusion criteria, including enrolling gender bias [25,26], enrolling merely members of a religious community [26,27,29], a limited age range [4,12], and a high level of education [26].”
BackgroundNelson, P. T., Brayne, C., Flanagan, M. E., Abner, E. L., Agrawal, S., Attems, J., Castellani, R. J., Corrada, M. M., Cykowski, M. D., Di, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02444-1 · Cited by 174
“1 3 following autopsy cohorts (in alphabetical order): Adult Changes in Thought (ACT) [58]; Brazilian Biobank for Aging Studies (BAS) of the University of Sao Paulo [106]; Cambridge City over-75 s Cohort (CC75C) [16]; Medical Research Council Cognitive Function and Ageing Study (CFAS) [115]; Duke University/University…”
InfluentialSelf-citationNeuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies
White, L. R., Edland, S. D., Hemmy, L. S., Montine, K. S., Zarow, C., Sonnen, J. A., Uyehara-Lock, J. H., Gelber, R. P., Ross, G. W., Petrovitch, H., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002480 · Cited by 171
“4 30 (9) 12 (40) 4 (13) 14 (47) 165 (21) 75 (46) 30 (18) 60 (36)”
A Population-Based Clinicopathological Study in the Oldest-Old: The 90+ Study
M. Corrada, M., J. Berlau, D., & H. Kawas, C. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322537 · Cited by 162
“Furthermore, studies have found that pathologies other than AD play a more important role in dementia expression of the oldest-old compared to younger elderly [27, 29, 30].”
BackgroundThe Epidemiology of Vascular Dementia
Ozbabalk, D., Arslanta, D., & Tuncer, N. (2012) · Geriatrics · doi:10.5772/25840 · Cited by 158
“Vascular dementia (VaD), describing impairments in cognitive function caused by problems in cerebral or cardiac blood vessels, is the second most common cause of dementia after Alzheimer disease in the aging population (Figure 2) (4).”
BackgroundChallenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154
“2008), the Cambridge City of 75s cohort/CC75C/(Brayne et al. 2009), the Honolulu-Asian Aging study/HAAS/(White et al.”
BackgroundVascular Cognitive Impairment and Dementia
Wong, E. C., & Chui, H. C. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001124 · Cited by 218
The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment
P. Gelber, R., J. Launer, L., & R. White, L. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322618 · Cited by 149
“More recently, microinfarct number and location have been identified as associated with cognitive impairment and dementia [21, 23-28].”
BackgroundMixed dementia: A review of the evidence
Custodio, N., Montesinos, R., Lira, D., Herrera-Pérez, E., Bardales, Y., & Valeriano-Lorenzo, L. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-040005 · Cited by 148
Suemoto, C. K., Ferretti-Rebustini, R. E. L., Rodriguez, R. D., Leite, R. E. P., Soterio, L., Brucki, S. M. D., Spera, R. R., Cippiciani, T. M., Farfel, J. M., Chiavegatto Filho, A., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002267 · Cited by 146
Cognitive and social lifestyle: links with neuropathology and cognition in late life
Bennett, D. A., Arnold, S. E., Valenzuela, M. J., Brayne, C., & Schneider, J. A. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1226-2 · Cited by 142
Self-citationDementia risk and prevention by targeting modifiable vascular risk factors
Tariq, S., & Barber, P. A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14132 · Cited by 136
“Rapid rates of atrophy differentiate persons with dementia from those without dementia in all age groups (Hubbard and Anderson 1981; Brayne et al. 2009).”
BackgroundDementia: definitions and types
Dening, T., & Sandilyan, M. B. (2015) · Nursing Standard · doi:10.7748/ns.29.37.37.e9405 · Cited by 207
Self-citationClinical and imaging features of mixed Alzheimer and vascular pathologies
Chui, H. C., & Ramirez-Gomez, L. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0104-7 · Cited by 124
“CC75 + C [14] 224 91 CERAD 22% of 113 dementia cases”
BackgroundInfluentialCompounding artefacts with uncertainty, and an amyloid cascade hypothesis that is ‘too big to fail’
Castellani, R. J., & Smith, M. A. (2011) · The Journal of Pathology · doi:10.1002/path.2885 · Cited by 121
Mayeda, E. R., Whitmer, R. A., & Yaffe, K. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.08.021 · Cited by 116
Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges
Castellani, R. J., & Perry, G. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180721 · Cited by 110
“This may explain substantial proteinopathy with intact cognition [118, 170, 173, 236], or the lack of a clinical correlate of p-tau pathology described in former athletes or military service members.”
BackgroundNichols, E., Merrick, R., Hay, S. I., Himali, D., Himali, J. J., Hunter, S., Keage, H. A. D., Latimer, C. S., Scott, M. R., Steinmetz, J. D., et al. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00019-3 · Cited by 108
Self-citationAlzheimer's disease outlook: controversies and future directions
Frisoni, G. B., Aho, E., Brayne, C., Ciccarelli, O., Dubois, B., Fox, N. C., Frederiksen, K. S., Gabay, C., Garibotto, V., Hofmarcher, T., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01389-3 · Cited by 135
Self-citationA critical review of chronic traumatic encephalopathy
Iverson, G. L., Gardner, A. J., McCrory, P., Zafonte, R., & Castellani, R. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.008 · Cited by 103
Park, M., & Moon, W.-J. (2016) · Korean Journal of Radiology · doi:10.3348/kjr.2016.17.6.827 · Cited by 100
“Cerebral Microinfarcts Emerging evidences shows that cerebral microinfarcts are associated with cardiovascular risk factors as well as cognitive decline and dementia, particularly if they are multiple and cortical (120, 121).”
BackgroundRisk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals
Ighodaro, E. T., Abner, E. L., Fardo, D. W., Lin, A.-L., Katsumata, Y., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Neltner, J. H., Monsell, S. E., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621574 · Cited by 98
Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease
Hunter, S., & Brayne, C. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.218 · Cited by 94
Self-citationTau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy
Chornenkyy, Y., Fardo, D. W., & Nelson, P. T. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0196-y · Cited by 93
Phenotypic heterogeneity in dementia: a challenge for epidemiology and biomarker studies
Ryan, J., Fransquet, P., Wrigglesworth, J., & Lacaze, P. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00181 · Cited by 91
A peculiar constellation of tau pathology defines a subset of dementia in the elderly
Kovács, G. G., Molnár, K., László, L., Ströbel, T., Botond, G., Hönigschnabl, S., Reiner‐Concin, A., Palkovits, M., Fischer, P. A., & Budka, H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0819-x · Cited by 96
“Moreover, the spectrum of alterations changes with age; patients show less severe ADrelated pathology (or discrepancy between amyloid plaque load and neurofibrillary degeneration [39]) but more vascular and mixed forms [7].”
BackgroundThe complexities of the pathology–pathogenesis relationship in Alzheimer disease
Castellani, R. J., & Perry, G. L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.009 · Cited by 101
“These data, and the fact that AD cannot be independently diagnosed in elderly subjects with any degree of accuracy on the basis of the neuropathology [35], indicates that pathology and”
BackgroundExtra-virgin olive oil for potential prevention of Alzheimer disease
Román, G. C., Jackson, R. E., Reis, J. J., Roman, A., Toledo, J. B., & Toledo, E. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.017 · Cited by 107
Alzheimer’s disease: as it was in the beginning
Kozlov, S. O., Afonin, A. М., Evsyukov, I., & Бондаренко, А. Б. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0006 · Cited by 95
Collaborators, G. 2. D. (2021) · Neuroepidemiology · doi:10.1159/000515393 · Cited by 87
Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank Volunteers
Dugger, B. N., Hentz, J. G., Adler, C. H., Sabbagh, M. N., Shill, H. A., Jacobson, S., Caviness, J. N., Belden, C., Driver-Dunckley, E., Davis, K. J., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000046 · Cited by 80
“Prevalence of VaD has been reported to range between 0% to 8% and 4% to 16% within dementia cases (8, 52, 53).”
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Hunter, S., & Brayne, C. (2017) · Journal of Negative Results in BioMedicine · doi:10.1186/s12952-017-0066-3 · Cited by 77
Self-citationAlzheimer’s/Vascular Spectrum Dementia: Classification in Addition to Diagnosis
Emrani, S., Lamar, M., Price, C. C., Wasserman, V., Matusz, E. F., Au, R., Swenson, R. A., Nagele, R. G., Heilman, K. M., & Libon, D. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190654 · Cited by 97
Latimer, C. S., Keene, C. D., Flanagan, M. E., Hemmy, L. S., Lim, K. O., White, L. R., Montine, K. S., & Montine, T. J. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx030 · Cited by 70
Barnes, J., Carmichael, O. T., Leung, K. K., Schwarz, C., Ridgway, G. R., Bartlett, J. W., Malone, I. B., Schott, J. M., Rossor, M. N., Biessels, G. J., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.003 · Cited by 70
“Alzheimer’s disease (AD) is the most common primary pathological cause of dementia, and vascular disease has been reported as the second most common (Brayne et al., 2009; Jellinger, 2006).”
Perrels, A., Fleming, J., Zhao, J. Y., Barclay, S. I. G., Farquhar, M. C., Buiting, H. M., & Brayne, C. (2013) · Palliative Medicine · doi:10.1177/0269216313510341 · Cited by 79
Self-citationCerebrovascular Disease, Amyloid Plaques, and Dementia
Liu, W., Wong, A., Law, A. C. K., & Mok, V. (2015) · Stroke · doi:10.1161/strokeaha.114.006571 · Cited by 76
Neuropathologic features associated with Alzheimer disease diagnosis: Age matters
Middleton, L. E., Grinberg, L. T., Miller, B., Kawas, C., & Yaffe, K. (2011) · Neurology · doi:10.1212/wnl.0b013e318236f0cf · Cited by 66
Microinfarcts are common and strongly related to dementia in the oldest‐old: The 90+ study
Corrada, M. M., Sonnen, J. A., Kim, R. C., & Kawas, C. H. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.006 · Cited by 67
“All 901 Study participants who agreed to in-person examination (N5 978) were invited to be part of the autopsy program [7].”
BackgroundResultInfluentialBullain, S., & Corrada, M. M. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000429172.27815.3f · Cited by 73
“7 years.(45) Microinfarcts are increasingly being investigated as an important cerebrovascular pathology in relation to cognition and may be as strong a predictor for dementia as AD.”
BackgroundPrevalence and Pathology of Vascular Dementia in the Oldest-Old1
Jellinger, K. A., & Attems, J. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100603 · Cited by 60
“…confounding effect of their comparison by the lack of common diagnostic criteria for VaD, and small numbers of very old individuals in most studies [17–20] and the fact that aged subjects with and without dementia show a high frequency of mixed pathologies and co-morbidities [21–36] (also see [7]).”
Jellinger, K. A., & Attems, J. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000327360 · Cited by 59
J. Montine, T., A. Sonnen, J., S. Montine, K., K. Crane, P., & B. Larson, E. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322555 · Cited by 58
Cholerton, B., Larson, E. B., Quinn, J. F., Zabetian, C. P., Mata, I. F., Keene, C. D., Flanagan, M. E., Crane, P. K., Grabowski, T. J., Montine, K. S., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.12.001 · Cited by 65
Kulas, J. A., Weigel, T. K., & Ferris, H. A. (2020) · Drug Development Research · doi:10.1002/ddr.21643 · Cited by 54
“Many people develop Aβ plaque deposits as they age and are not symptomatic for AD (Brayne et al., 2009), thus amyloid alone cannot explain the AD phenomenon.”
BackgroundCan Stroke Cause Neurodegenerative Dementia?
Cumming, T. B., & Brodtmann, A. G. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00666.x · Cited by 57
Is there pure vascular dementia in old age?
Jellinger, K. A., & Attems, J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.038 · Cited by 68
Hypertension and Alzheimer's disease: is the picture any clearer?
Lennon, M. J., Koncz, R., & Sachdev, P. S. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000684 · Cited by 55
“UK autopsy studies have variously found mixed vascular and AD dementia pathology in 22–70% of cases with pure AD ranging from 4 to 67% of all dementia cases [59,60].”
BackgroundSibbett, R. A., Russ, T. C., Deary, I. J., & Starr, J. M. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1401-4 · Cited by 49
Walsh, P., Sudre, C. H., Fiford, C. M., Ryan, N. S., Lashley, T., Frost, C., & Barnes, J. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.008 · Cited by 49
Davis, G. A., Castellani, R. J., & McCrory, P. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000722 · Cited by 47
“This demonstrates that while these lesions are associated with the clinical syndrome in life in many individuals, in others there are no clinical manifestations, and the pathological abnormalities may represent normal aging.(89,90) This clinicopathological disconnection has been demonstrated in other aging studies.”
ResultWalsh, S., Causer, R., & Brayne, C. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1699019 · Cited by 51
“…between clinical and pathological findings, with some individuals not developing the dementia syndrome despite large burdens of neuropathology (C Brayne et al., 2001; C. Brayne et al., 2009; Robert Katzman et al., 1988; Matthews et al. 2009; Schneider, Arvanitakis, Leurgans, & Bennett, 2009).”
BackgroundSelf-citationNelson, R. S., Abner, E. L., Jicha, G. A., Schmitt, F. A., Di, J., Wilcock, D. M., Barber, J. M., Eldik, L. J. V., Katsumata, Y., Fardo, D. W., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01576-z · Cited by 45
“A rapidly expanding literature supports the concept of additive (but not necessarily synergistic) impact on cognitive status [1, 2, 13, 18, 34, 37].”
BackgroundHigginbotham, L. A., Carter, E. K., Dammer, E. B., Haque, R. U., Johnson, E. C. B., Duong, D. M., Yin, L., Jager, P. L. D., Bennett, D. A., Felsky, D., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106286 · Cited by 43
Small Vascular and Alzheimer Disease-Related Pathologic Determinants of Dementia in the Oldest-Old
Sinka, L., Kövari, E., Gold, G., Hof, P. R., Herrmann, F. R., Bouras, C., & Giannakopoulos, P. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ffc3b9 · Cited by 43
Chronic Effects of Mild Neurotrauma: Putting the Cart Before the Horse?
Castellani, R. J., Perry, G., & Iverson, G. L. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000193 · Cited by 40
“Moreover, blinded neuropathologic examination cannot reliably and accurately distinguish dementia in persons older than 80 years from the cognitively intact (61).”
Population‐based analysis of pathological correlates of dementia in the oldest old
Tanskanen, M., Mäkelä, M., Notkola, I., Myllykangas, L., Rastas, S., Oinas, M., Lindsberg, P. J., Polvikoski, T., Tienari, P. J., & Paetau, A. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.389 · Cited by 40
“These findings are consistent with previous longitudinal studies investigating neuropathological correlates of dementia.(13,26,27,28,29,35,36,37) Several studies also have demonstrated a strong association between high CERAD score and dementia, but the results in the multivariate analyses have varied.”
ResultA European perspective on population studies of dementia
Brayne, C., Stephan, B. C. M., & Matthews, F. E. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.003 · Cited by 40
Self-citationSolanezumab and the amyloid hypothesis for Alzheimer’s disease
Le Couteur, D. G., Hunter, S., & Brayne, C. (2016) · BMJ · doi:10.1136/bmj.i6771 · Cited by 40
Self-citationDavey, D. A. (2013) · Women s Health · doi:10.2217/whe.13.22 · Cited by 48
“There is a continuum in the pathophysiology of normal aging and AD and at autopsy up to 75% of cognitively normal elderly patients have changes similar to those found in the brain of individuals with AD dementia [17,18].”
BackgroundMolecular Links and Biomarkers of Stroke, Vascular Dementia, and Alzheimer's Disease
Vijayan, M., Kumar, S., Bhatti, J. S., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.014 · Cited by 41
“The annual incidence of VaD may range from 20 to 40 per 100,000 in individuals aged 60–69 years, to 200–700 per 100,000 in individuals over age 80 years.(20)”
BackgroundInsulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses
Alves, S. S., da Silva-Júnior, R. M. P., Servilha‐Menezes, G., Homolak, J., Šalković‐Petrišić, M., & Garcia‐Cairasco, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210234 · Cited by 43
study, O. B. O. T. C. C. O.-7. C. (., Fleming, J., Calloway, R., Perrels, A., Farquhar, M. C., Barclay, S. I. G., & Brayne, C. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0605-2 · Cited by 52
“This diagnosis was based on review of all available information including survey data, proxy informant data, general practitioner (GP) confirmation of dementia diagnosis, death certificates and data from retrospective informant interviews after participants had died [62].”
MethodSelf-citationTanskanen, M., Mäkelä, M. J., Myllykangas, L., Notkola, I. ‐., Polvikoski, T. M., Sulkava, R. O., Kalimo, H., & Paetau, A. E. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01219.x · Cited by 46
A History of Senile Plaques: From Alzheimer to Amyloid Imaging
Beach, T. G. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac030 · Cited by 41
Walker, L., Simpson, H., Thomas, A. J., & Attems, J. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01714-7 · Cited by 39
Oken, B., Kaplan, J., Klee, D., & Gallegos, A. M. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2024.1380002 · Cited by 40
Azarpazhooh, M. R., Avan, A., Cipriano, L. E., Munoz, D. G., Erfanian, M., Amiri, A., Stranges, S., & Hachinski, V. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.101002 · Cited by 32
Frailty and neuropathology in relation to dementia status: the Cambridge City over-75s Cohort study
Wallace, L. M. K., Hunter, S., Theou, O., Fleming, J., Rockwood, K. J., & Brayne, C. (2021) · International Psychogeriatrics · doi:10.1017/s1041610220003932 · Cited by 33
“…improved when both frailty index and neuropathological index are included in a model for dementia status Frailty, neuropathology, and dementia 1039 has shown to have cognitive score distributions that closely match those of the full cohort (Brayne et al. , 2009; EClipSE Collaboration, 2009).”
InfluentialSelf-citationWhitehouse, P. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.017 · Cited by 32
Neuropathological lesions in the very old: results from a large Brazilian autopsy study
Suemoto, C. K., Leite, R. E. P., Ferretti‐Rebustini, R. E. D. L., Rodriguez, R. D., Nitríni, R., Pasqualucci, C. A., Filho, W. J., & Grinberg, L. T. (2019) · Brain Pathology · doi:10.1111/bpa.12719 · Cited by 36
“The inclusion of a younger age group with preclinical disease is an important strength since individual below 80 years old were underrepresented in previous studies (6, 21, 28).”
BackgroundMemory Binding Test Predicts Incident Amnestic Mild Cognitive Impairment
Mowrey, W. B., Lipton, R. B., Katz, M. J., Ramratan, W. S., Loewenstein, D., Zimmerman, M. E., & Herman Buschke, L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160291 · Cited by 32
“Finally, multiple studies have shown that in patients clinically diagnosed with AD there are often comorbid neuropathologic abnormalities such as subcortical small vessel disease, microinfarcts, Lewy bodies and hippocampal sclerosis [45–47].”
Katsel, P., Roussos, P., Beeri, M. S., Gama-Sosa, M. A., Gandy, S., Khan, S., & Haroutunian, V. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206547 · Cited by 29
Metadata
- Authors
- Brayne, C., the Cambridge City over-75s Cohort (CC75C) study neuropathology collaboration, Richardson, K., Matthews, F. E., Fleming, J., Hunter, S., Xuereb, J. H., Paykel, E., Mukaetova-Ladinska, E. B., Huppert, F. A., O'Sullivan, A., & Dening, T.
- Affiliations
- University of Cambridge (GB)
- MRC Biostatistics Unit (GB)
- Institute for Ageing and Health, Newcastle University, Wolfson Research Centre, Campus for Ageing and Vitality, Newcastle upon Tyne, UK
- Fulbourn Hospital (GB)
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-10-30
- Volume
- 18
- Issue
- 3
- Pages
- 645-658
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2145741244
- Cited by
- 191
- References
- 32
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 5 · 2023: 14 · 2022: 8 · 2021: 10 · 2020: 7 · 2019: 13 · 2018: 11 · 2017: 15 · 2016: 18 · 2015: 13 · 2014: 12 · 2013: 11 · 2012: 16
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Bupa Foundation
- National Institutes of Health
- NIHR Cambridge Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- late-onset dementia, Alzheimer's disease
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Catchment Area, Health, Dementia, Female, United Kingdom, Humans, Male, Population Surveillance, Tissue Donors, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.